The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zuev A.V.

Immanuil Kant Baltic Federal University, Ministry of Education and Science, Kaliningrad, Russia;
Center for Specialized Types of Medical Care of the Kaliningrad Region, Kaliningrad, Russia

Shperling N.V.

Voenno-meditsinskaia akademiia im. S.M. Kirova, Sankt-Peterburg

Sharopina A.A.

Nauchno-prakticheskiĭ tsentr professional'noĭ perepodgotovki po dermatovenerologii i kosmetologii GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava Rossii, Tomsk

Kruk E.A.

Nauchno-prakticheskiĭ tsentr professional'noĭ perepodgotovki po dermatovenerologii i kosmetologii GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava Rossii, Tomsk

Gontar A.A.

Immanuil Kant Baltic Federal University, Ministry of Education and Science, Kaliningrad, Russia

Stovbun S.V.

Institut khimicheskoĭ fiziki im. N.N. Semenova RAN, Moskva

Kucherov V.A.

2OOO "Bio Farma", Moskva

Safronov D.V.

Nauchno-prakticheskiĭ tsentr professional'noĭ perepodgotovki po dermatovenerologii i kosmetologii GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava Rossii, Tomsk

Bagaeva M.I.

Kafedra akusherstva i ginekologii Rossiĭskoĭ gosudarstvennoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva

Rationale for the use and efficacy of a virostatic static drug with an immunomodulating effect and in patients with different types of genital herpes simplex

Authors:

Zuev A.V., Shperling N.V., Sharopina A.A., Kruk E.A., Gontar A.A., Stovbun S.V., Kucherov V.A., Safronov D.V., Bagaeva M.I.

More about the authors

Read: 1056 times


To cite this article:

Zuev AV, Shperling NV, Sharopina AA, et al. Rationale for the use and efficacy of a virostatic static drug with an immunomodulating effect and in patients with different types of genital herpes simplex. Russian Journal of Clinical Dermatology and Venereology. 2012;10(6):60‑64. (In Russ.)

References:

  1. Masyukova S.A., Vladimirova E.V., Glad'ko O.V. Perspektivy i vozmozhnosti profilakticheskoi terapii genital'nogo gerpesa. Consilium Medicum 2003; 3: 168-170.
  2. Khaldin A.A., Ignat'ev D.V. Viferon gel' pri lechenii prostogo gerpesa. Consilium Medicum 2008; 2: 35-38.
  3. Vasil'ev M.M., Denisova V.M. Epidemiologiya, diagnostika i lechenie bol'nykh s erozivno-yazvennymi porazheniyami polovykh organov, assotsiirovannymi s bakterial'noi infektsiei, a takzhe virusami iz semeistva gerpesov. Klin dermatol i venerol 2009; 1: 16-22.
  4. Makhmudov F.R. Sovremennye podkhody k lecheniyu genital'nogo gerpesa. Klin dermat i venerol 2008; 6: 51-54.
  5. Khaldin A.A., Ignat'ev D.V., Vasil'ev A.N. Prostoi gerpes: etiologiya, patogenez, diagnostika, lechenie. Consilium Medicum 2009; 1: 35-39.
  6. Shul'zhenko A.E. Gerpeticheskie infektsii cheloveka, perspektivy diagnostiki i protivovirusnoi terapii. Ros zhurn kozhn i ven bol 2006; 1: 51-58.
  7. Chebotarev V.V., Dzhegutanov K.E. Lechenie bol'nykh genital'nym gerpesom. Sib zhurn dermatol i venerol 2002; 3: 41-43.
  8. Kuzovkova T.V., Gerasimova N.M., Kungurov N.V. Immunotropnaya terapiya retsidiviruyushchego genital'nogo gerpesa. Klin dermatol i venerol 2005; 4: 54-56.
  9. Patel R., Barton S.E., Brown D. et al. European guideline for the management of genital herpes. Int J STD AIDS 2001; 12: 3: 34-39.
  10. Whitley R.J. Optimizing the management of genital herpes. Round Table Series 2000; 69: 66.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.